The new standard of care: Alemtuzumab induction with Tacrolimus and Sirolimus maintenance immunosuppression to limit acute and chronic allograft rejection.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Hoffmann, SC; Kampen, RL; Pearl, JP; Hale, DA; Jacobson, LM; Kleiner, DE; Mannon, RB; Muehrer, RJ; Swanson, SJ; Becker, BN; Kirk, AD

Published Date

  • January 1, 2004

Published In

Volume / Issue

  • 4 /

Start / End Page

  • 332 - 332

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1600-6135

Conference Name

  • American Transplant Congress

Conference Location

  • Boston, MA

Conference Start Date

  • May 14, 2004

Conference End Date

  • May 19, 2004